The Pharmacology of Longevity: Peptide Edition (Part 1) BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification BPC 157: Miracle Healing Peptide or Hidden Danger? The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and clinics. With BPC 157, TB 500, and others under 503A review, questions around compounding, compliance, and what is New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,